Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C ECKERT

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Leukemia|May 7, 2015
ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemiaM Zaliova, O Zimmermannova, P Dörge, et al.
Breast Cancer Research and Treatment|January 1, 1981
Adjuvant therapy of stage II breast cancer: 48-month follow-up of a prospective randomized clinical trialC A Hubay, O H Pearson, J S Marshall, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 6, 2018
Guidance document for prevention of Clostridium difficile infection in acute healthcare settingsS Tschudin-Sutter, E J Kuijper, A Durovic, et al.
Leukemia|April 27, 2007
Childhood secondary ALL after ALL treatmentJ Zuna, H Cavé, C Eckert, et al.
Leukemia|December 1, 2016
Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemiaC Vesely, C Frech, C Eckert, et al.
American Journal of Epidemiology|September 10, 2024
Emulations of oncology trials using real-world data: a systematic literature reviewJennifer R Rider, Asher Wasserman, Lukas Slipski, et al.
Pharmacoepidemiology and Drug Safety|October 28, 2024
The Oncology QCARD Initiative: Fostering efficient evaluation of initial real-world data proposalsDonna R Rivera, Joy C Eckert, Carla Rodriguez-Watson, et al.
Leukemia|April 29, 2015
KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemiaK Malinowska-Ozdowy, C Frech, A Schönegger, et al.
Blood Cancer Journal|February 4, 2017
Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemiaP Richter-Pechańska, J B Kunz, J Hof, et al.
Leukemia|February 9, 2007
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR dataV H J van der Velden, G Cazzaniga, A Schrauder, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Leukemia|May 7, 2015
ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemiaM Zaliova, O Zimmermannova, P Dörge, et al.
Breast Cancer Research and Treatment|January 1, 1981
Adjuvant therapy of stage II breast cancer: 48-month follow-up of a prospective randomized clinical trialC A Hubay, O H Pearson, J S Marshall, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 6, 2018
Guidance document for prevention of Clostridium difficile infection in acute healthcare settingsS Tschudin-Sutter, E J Kuijper, A Durovic, et al.
Leukemia|April 27, 2007
Childhood secondary ALL after ALL treatmentJ Zuna, H Cavé, C Eckert, et al.
Leukemia|December 1, 2016
Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemiaC Vesely, C Frech, C Eckert, et al.
American Journal of Epidemiology|September 10, 2024
Emulations of oncology trials using real-world data: a systematic literature reviewJennifer R Rider, Asher Wasserman, Lukas Slipski, et al.
Pharmacoepidemiology and Drug Safety|October 28, 2024
The Oncology QCARD Initiative: Fostering efficient evaluation of initial real-world data proposalsDonna R Rivera, Joy C Eckert, Carla Rodriguez-Watson, et al.
Leukemia|April 29, 2015
KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemiaK Malinowska-Ozdowy, C Frech, A Schönegger, et al.
Blood Cancer Journal|February 4, 2017
Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemiaP Richter-Pechańska, J B Kunz, J Hof, et al.
Leukemia|February 9, 2007
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR dataV H J van der Velden, G Cazzaniga, A Schrauder, et al.
Pageof 14